|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 2.060 USD | -1.44% |
|
+5.10% | +14.44% |
| 13/05 | Protalix BioTherapeutics, Inc., Q1 2026 Earnings Call, May 13, 2026 | |
| 13/05 | Protalix BioTherapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2026 | CI |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Sector Other Pharmaceuticals
| Capi. | Sales Growth | Profitability | Finances | EV / Sales | P/E | |
|---|---|---|---|---|---|---|
 | 17Cr | - | - | |||
| 1,01000Cr | |||||
| 58TCr | |||||
| 40TCr | |||||
| 33TCr | |||||
| 28TCr |
Select your edition
All financial news and data tailored to specific country editions
